Anzeige
❌
Mehr »
Freitag, 09.10.2026 - Börsentäglich über 12.000 News
Elevate Sercive Group: Neue Expertise für den nächsten Wachstumsschritt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von x3news

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
10.09.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
10.09.Eurohold Bulgaria AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
10.09.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
10.09.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
10.09.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
09.09.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
09.09.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
09.09.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
09.09.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
08.09.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
08.09.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
04.09.Shelly Group SE: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
04.09.Telelink Business Services Group AD: Invitation and materials for a General shareholders meeting
04.09.Starcom Holding AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
04.09.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
04.09.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
04.09.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
04.09.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
02.09.Shelly Group SE: Other unregulated information
02.09.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
02.09.Starcom Holding AD: Consolidated quarterly financial report
02.09.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
02.09.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014
02.09.Starcom Holding AD: Quarterly report about obligations' fulfilment related to a bond issue in pursuance of Art. 100f (1), item 2 in relation to Art. 100f (2) of the POSA
02.09.Starcom Holding AD: Quarterly report about obligations' fulfilment related to a bond issue in pursuance of Art. 100f (1), item 2 in relation to Art. 100f (2) of the POSA